Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704001 | SCV000521398 | likely benign | not provided | 2021-02-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28078312, 28407228) |
Invitae | RCV000468209 | SCV000558473 | benign | Brugada syndrome | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000419590 | SCV000700598 | benign | not specified | 2013-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390239 | SCV002696886 | likely benign | Cardiovascular phenotype | 2019-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000419590 | SCV002034478 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001704001 | SCV002037321 | likely benign | not provided | no assertion criteria provided | clinical testing |